Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10,638,857
-
Total 13F shares
-
7,999,743
-
Share change
-
-1,202,134
-
Total reported value
-
$85,931,464
-
Put/Call ratio
-
8.2%
-
Price per share
-
$10.68
-
Number of holders
-
102
-
Value change
-
-$13,672,467
-
Number of buys
-
33
-
Number of sells
-
72
Institutional Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q4 2025
As of 31 Dec 2025,
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,999,743 shares.
The largest 10 holders included
BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, VANGUARD GROUP INC, MORGAN STANLEY, Lido Advisors, LLC, DIMENSIONAL FUND ADVISORS LP, Steamboat Capital Partners, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Man Group plc.
This page lists
103
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.